首页 | 本学科首页   官方微博 | 高级检索  
   检索      

结核分枝杆菌H37Rv新基因Rv2742克隆表达及纯化
引用本文:赵加玲,武舒佳,王红,李芊璘,孙金帅,常蕾,戴二黑,武军驻,张瑶,徐平.结核分枝杆菌H37Rv新基因Rv2742克隆表达及纯化[J].生物工程学报,2019,35(9):1771-1786.
作者姓名:赵加玲  武舒佳  王红  李芊璘  孙金帅  常蕾  戴二黑  武军驻  张瑶  徐平
作者单位:1 武汉大学 药学院,湖北 武汉 430000;3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206,2 武汉大学 基础医学院,湖北 武汉 430000;3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206,3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206;4 华北理工大学 公共卫生学院和附属石家庄市第五医院,河北 唐山 063210,4 华北理工大学 公共卫生学院和附属石家庄市第五医院,河北 唐山 063210,3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206;5 河北大学 生命科学学院,河北 保定 071000,3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206,4 华北理工大学 公共卫生学院和附属石家庄市第五医院,河北 唐山 063210,2 武汉大学 基础医学院,湖北 武汉 430000,3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206;6 中山大学 生命科学学院,广东 广州 510275,1 武汉大学 药学院,湖北 武汉 430000;3 军事科学院军事医学研究院生命组学研究所 国家蛋白质科学中心 (北京) 北京蛋白质组研究中心 蛋白质组学国家重点实验室,北京 102206
基金项目:国家精准医学重大专项 (No. 2017YFC0906600),国家传染病重大专项 (No. 2018ZX10302302001003),国家自然科学基金 (Nos. 31670834,31870824,91839302),广东省基础及应用基础研究博士科研启动项目 (No. 2018A030310257) 资助。
摘    要:Rv2742是本课题组前期基于蛋白质基因组学策略从结核分枝杆菌Mycobacteriumtuberculosis H37Rv中发现、鉴定的遗漏注释基因。文中旨在建立结核分枝杆菌H37Rv漏注释蛋白Rv2742的可溶性诱导表达、纯化体系,为进一步探索Rv2742基因参与的生物学功能奠定基础。前期实验发现构建的pGEX-4T-2-Rv2742、pET-28a-Rv2742、pET-32a-Rv2742及pMAL-c2X-Rv2742原核表达载体均无法实现目的蛋白的诱导表达。但经密码子优化后,仅有pMAL-c2X-Rv2742载体能够实现目的蛋白的可溶性诱导表达。此外,通过比较不同宿主菌、温度及IPTG浓度对目的蛋白表达量的影响,发现目的蛋白在Rosetta (DE3)中,16℃及0.5mmol/LIPTG诱导条件下表达量最高。直链淀粉树脂(Amyloseresin)亲和层析柱纯化获得较纯的产物,经LC-MS/MS验证确认是Rv2742融合蛋白肽段序列。成功获得结核分枝杆菌H37Rv新基因Rv2742的重组蛋白,可进一步开展其潜在相互作用及免疫原性研究工作。

关 键 词:结核分枝杆菌,新基因,原核表达,亲和纯化
收稿时间:2019/3/12 0:00:00

Cloning, expression and purification of novel gene Rv2742 in Mycobacterium tuberculosis H37Rv
Jialing Zhao,Shujia Wu,Hong Wang,Qianlin Li,Jinshuai Sun,Lei Chang,Erhei Dai,Junzhu Wu,Yao Zhang and Ping Xu.Cloning, expression and purification of novel gene Rv2742 in Mycobacterium tuberculosis H37Rv[J].Chinese Journal of Biotechnology,2019,35(9):1771-1786.
Authors:Jialing Zhao  Shujia Wu  Hong Wang  Qianlin Li  Jinshuai Sun  Lei Chang  Erhei Dai  Junzhu Wu  Yao Zhang and Ping Xu
Institution:1 School of Pharmaceutical Sciences, Wuhan University, Wuhan 430000, Hubei, China;3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China,2 School of Basic Medical Sciences, Wuhan University, Wuhan 430000, Hubei, China;3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China,3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China;4 School of Public Health and Affiliated Shijiazhuang Fifth Hospital, North China University of Science and Technology, Tangshan 063210, Hebei, China,4 School of Public Health and Affiliated Shijiazhuang Fifth Hospital, North China University of Science and Technology, Tangshan 063210, Hebei, China,3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China;5 School of Life Sciences, Hebei University, Baoding 071000, Hebei, China,3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China,4 School of Public Health and Affiliated Shijiazhuang Fifth Hospital, North China University of Science and Technology, Tangshan 063210, Hebei, China,2 School of Basic Medical Sciences, Wuhan University, Wuhan 430000, Hubei, China,3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China;6 School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, Guangdong, China and 1 School of Pharmaceutical Sciences, Wuhan University, Wuhan 430000, Hubei, China;3 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China
Abstract:Rv2742 is a novel gene identified from Mycobacterium tuberculosis H37Rv by the proteogenomics strategy. The aim of this study was to establish a system of soluble expression and purification of the missing protein Rv2742 in M. tuberculosis H37Rv, to provide reference for further research on the biological function of Rv2742. The soluble protein was not successfully induced by prokaryotic expression vectors pGEX-4T-2-Rv2742, pET-32a-Rv2742, pET-28a-Rv2742 and pMAL-c2X-Rv2742. After the codon of novel gene Rv2742 was optimized according to E. coli codon usage frequency, only the recombinant strain containing plasmid pMAL-c2X-Rv2742 could produce soluble products of Rv2742 encoding gene. In addition, the expression effects of the desired fusion protein were also analyzed under different conditions including hosts, culture temperatures and IPTG concentrations. The optimum expression conditions were as follows: Rosetta (DE3) host, 16 °C culture temperature and 0.5 mmol/L IPTG. After being purified by affinity chromatography with amylose resin, the fusion protein sequence was confirmed by LC-MS/MS. These results indicated that the novel gene Rv2742 product could be successfully induced and expressed in a soluble form by the expression system pMAL-c2X with MBP tag. Our findings provide reference for studies on potential interaction and immunogenicity.
Keywords:Mycobacterium tuberculosis  novel gene  prokaryotic expression  affinity purification
本文献已被 CNKI 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号